Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme.
Yiqiao XinAndrew DaviesAndrew BriggsLouise McCombieC Martina MessowEleanor GrieveWilma S LeslieRoy TaylorMichael Ernest John LeanPublished in: Diabetologia (2020)
ISRCTN03267836 Graphical abstract.
Keyphrases
- type diabetes
- clinical trial
- study protocol
- glycemic control
- phase ii
- phase iii
- disease activity
- cardiovascular disease
- ulcerative colitis
- weight loss
- open label
- randomized controlled trial
- body mass index
- physical activity
- rheumatoid arthritis
- double blind
- systemic lupus erythematosus
- weight gain
- metabolic syndrome
- placebo controlled